Q3 2023 Sun Pharmaceutical Industries Ltd Earnings Call Transcript
Hello and a warm welcome to our Third Quarter FY '23 earnings call. I am Abhishek from the Sun Pharma Investor Relations Team. We hope you have received the Q3 financials and the press release that was sent out earlier in the day. These are also available on our website.
We have with us Mr. Dilip Shanghvi, Managing Director; Mr. C. Muralidharan, CFO; Mr. Abhay Gandhi , CEO-North America; and Mr. Kirti Ganorkar, CEO-India Business. Today, the team will discuss financial performance for the quarter, business highlights and respond to any questions that you may have. For ease of discussion, we will look at the consolidated financials. The call recording and the call transcript will also be put up on our website shortly.
The discussion today might include certain forward-looking statements, and these must be viewed in conjunction with the risks that the business faces. (Operator Instructions) I will now hand over the call to Mr. Shanghvi.
Thank
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
